Ketamine vs benzodiazepines for depression and anxiety

If you've tried antidepressants without lasting relief, you've probably started looking at other options. Ketamine and benzodiazepines both come up in those searches, but they treat different problems and work in almost opposite ways.

The short answer: Ketamine may help treatment-resistant depression by prompting your brain to form new connections, while benzodiazepines offer short-term calm for anxiety or panic. They aren't interchangeable, and knowing which problem you're solving shapes the right choice.

Roughly one in three people with depression don't respond fully to standard antidepressants. If that's your experience, that's not a personal failing. It's a signal that a different mechanism might be worth exploring.

What is ketamine therapy?

Ketamine started as an anesthetic. Over the past two decades, it has also shown antidepressant effects, often within hours rather than the weeks most antidepressants require.

It works on a different brain system than traditional medications. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) adjust mood-signaling chemicals gradually. Ketamine takes another route entirely: it triggers glutamate production, which prompts the brain to form new neural connections. Traditional antidepressants don't produce this kind of rapid rewiring, which is part of why ketamine can work when they haven't.

Using ketamine for depression and anxiety is considered off-label. The Food and Drug Administration (FDA) approved ketamine as an anesthetic, not for psychiatric conditions. A refined nasal-spray version called esketamine did receive FDA approval for treatment-resistant depression in 2019, and it's given in certified clinics under monitoring.

Ketamine comes in three main forms:

1. Intravenous (IV) infusions at specialized clinics
2. FDA-approved esketamine nasal spray (Spravato)
3. Oral ketamine

IV infusions require clinic visits and Esketamine must be administered in a certified clinical setting with at least two hours of monitoring after each dose. Some programs offer at-home therapy through sublingual tablets, with clinical oversight throughout.

What are benzodiazepines?

Benzodiazepines are prescription medications that slow down activity in your brain and nervous system. Common names include Xanax (alprazolam), Valium (diazepam), Ativan (lorazepam), and Klonopin (clonazepam).

They calm you quickly, which is why they're prescribed for panic attacks, short-term anxiety, seizures, and insomnia. That speed is their main advantage.

Benzodiazepines are meant to be short-term, typically two to four weeks. They haven't been shown to produce lasting improvement in anxiety on their own. For depression specifically, they aren't a treatment. In mood disorders, they're generally discouraged because they can worsen suicidal thoughts.

Key differences that affect your decision

The two medications pull your brain in opposite directions. Benzodiazepines press a chemical brake on an overactive nervous system. Ketamine lifts a brake that depression has placed on it and prompts neuroplastic changes that let neurons form new connections. One quiets your brain temporarily. The other tries to rebuild it.

Speed and duration

Both work fast, but for different reasons. Benzodiazepines calm anxiety within minutes because they act directly on your nervous system. Ketamine's antidepressant effect can appear within 40 to 60 minutes and often peaks around day one, which is fast for a depression treatment.

Early improvement sometimes starts as less heaviness in the morning or more ability to start tasks, rather than an overnight transformation.

After the initial relief, the treatments diverge. Benzodiazepine relief fades as the drug clears. Ketamine's effect from a single infusion typically lasts three to seven days, and a full course extends that further.

In a controlled trial, people who received ketamine were more than twice as likely to respond within 24 hours compared to those who received a benzodiazepine. But effects can wear off, which is why most treatment plans involve repeated sessions with therapy alongside them.

Cost and access

Generic benzodiazepines are inexpensive and commonly covered by insurance. A generic bottle can run under $20.

Ketamine varies more. IV infusions at clinics typically cost $400 to $800 per session and are rarely covered by insurance. FDA-approved esketamine has better insurance pathways but requires supervised clinic visits. At-home sublingual programs sit at a different price point, which is covered in the Innerwell section below.

Long-term safety risks

Ketamine carries more acute, in-the-moment effects. During a session you might feel dissociation, dizziness, nausea, or a temporary rise in blood pressure. Most side effects are mild and fade within a few hours. At therapeutic doses, ketamine has not shown physical dependence or dangerous withdrawal.

Benzodiazepines feel calming in the moment, but their risks build over time. Roughly 35% of people who take them for more than four weeks develop physical dependence, and stopping abruptly can trigger seizures. In 2020, the FDA required a boxed warning on all benzodiazepines for misuse, dependence, and withdrawal.

For older adults, the concern sharpens. All benzodiazepines appear on the American Geriatrics Society Beers Criteria as potentially inappropriate due to falls, cognitive impairment, and fracture risk.

If you currently take a benzodiazepine

If you're considering ketamine therapy while on a benzodiazepine, the two can work against each other.

Benzodiazepines can dampen ketamine's antidepressant effect. People taking benzodiazepines tend to respond more slowly, reach remission less often, and relapse sooner. The reason is pharmacological: benzodiazepines increase the very calming signal that ketamine is trying to lift.

That doesn't mean you can't start ketamine while on a benzodiazepine, but the two shouldn't overlap carelessly. Clinicians typically recommend a gradual taper, under supervision and never abruptly, before or during the transition to ketamine.

Early research also suggests ketamine itself may ease that transition. A preliminary study found that 91% of people with treatment-resistant depression discontinued long-term benzodiazepines during a four-week course of ketamine infusions, and fewer than 25% had a significant worsening of withdrawal. The sample was small, but the results point toward a possibility that matters if you're stuck on a medication you'd rather not take.

Which might fit your situation

Your treatment history, current symptoms, and overall health all shape this decision.

When ketamine may fit

Ketamine may make sense if you have depression that hasn't responded to at least two antidepressant trials. That history matters: ketamine is a third-line option for treatment-resistant depression, and one form (esketamine) has an FDA indication for depression with acute suicidal thoughts.

If you have both depression and anxiety, which is common for people on benzodiazepines, ketamine research has shown meaningful anxiety improvements alongside its antidepressant effects. You can learn more about whether you might be a good candidate.

When a benzodiazepine may fit

A short-term benzodiazepine may make sense if you need brief, acute relief from panic while a longer-term treatment takes hold, and you have no history of substance use disorder.

When neither is the right fit

Some situations point away from both. Benzodiazepines aren't recommended for post-traumatic stress disorder (PTSD), and ketamine doesn't have guideline support for PTSD as a standalone diagnosis, though people with trauma histories and treatment-resistant depression aren't automatically excluded.

Ketamine likely isn't appropriate if you have an active substance use concern, uncontrolled high blood pressure, or a history of psychosis. Innerwell's clinical evaluation sorts through these questions before treatment starts, including whether a current benzodiazepine needs to be adjusted first.

Bring a complete medication list to your evaluation, along with your prior treatment history and any safety concerns.

How Innerwell's at-home ketamine therapy works

Innerwell pairs sublingual ketamine with licensed therapeutic support, so the medication and the work of change happen together. This isn't ketamine dropped off with minimal supervision. Every therapist holds a Master's or Doctoral degree and is trained in psychedelic medicine.

Ketamine may open a window of neuroplastic flexibility; integration therapy helps you use that window intentionally. Without that support, effects tend to fade faster.

The process:

1. Clinical evaluation: A virtual psychiatric assessment reviews your history, including any current medications like benzodiazepines, to determine whether ketamine therapy is a safe fit.
2. Secure delivery: Sublingual ketamine tablets are shipped to your door with clinical support throughout.
3. Preparation and integration: Licensed therapists guide intention-setting before each dose and help you process what surfaces afterward. How you use this window tends to shape how lasting the change is.
4. Ongoing monitoring: Your care team tracks progress through telehealth and secure communication, then adjusts treatment as needed.

Pricing:

Plans start at $54 per session with insurance and $83 per session self-pay, compared to the $400 to $800 typical of standalone IV clinics. Insurance coverage is available in California and New York, with superbills for out-of-network reimbursement and self-pay options available elsewhere. Costs vary by plan.

Program outcomes:

In Innerwell's program, 87% of people see improvement within the first 4 weeks. After 10 weeks, the average reduction in depression symptoms is 69%, and anxiety symptoms decrease by 60%. For people who have spent months or years waiting for medications to work, that timeline can feel like a different experience entirely. The program holds a 4.7 out of 5 average rating.

Take the free assessment to see if ketamine therapy might work for you.

Frequently asked questions

How long is a full course of ketamine therapy?

Most programs involve an initial series of sessions over several weeks, followed by maintenance doses as needed. In Innerwell's program, your care team tailors the plan after your clinical evaluation and adjusts frequency based on how you respond. Some people find lasting improvement after one course; others benefit from periodic sessions over a longer period.

Is at-home ketamine as effective as IV infusions?

Sublingual ketamine has shown antidepressant effects in clinical use, and research continues to grow. The main advantage of at-home programs is that they pair the medication with ongoing therapeutic support, which IV clinics often don't include. That combination matters: ketamine with therapy tends to produce more durable improvement than either alone.

What if my anxiety is worse than my depression?

Ketamine's strongest research is in treatment-resistant depression, not standalone anxiety. That said, depression and anxiety overlap frequently, and Innerwell's program has shown a 60% reduction in anxiety symptoms after 10 weeks as a secondary outcome. If anxiety is your primary concern without significant depression, Innerwell's clinical team can help you figure out during the evaluation whether ketamine is the right fit.

What does the transition from a benzodiazepine to ketamine actually look like?

It depends on your situation. Some people taper their benzodiazepine before starting ketamine; others begin ketamine while adjusting their benzo dose under supervision. The taper is always gradual, never abrupt, and your care team monitors for withdrawal throughout. Innerwell's evaluation specifically assesses whether and how to manage this transition safely.

Are there people who shouldn't try either option?

Yes. Ketamine isn't appropriate for people with active psychosis, uncontrolled high blood pressure, or certain substance use concerns. Benzodiazepines carry serious risks for people with substance use histories and aren't recommended for long-term use in older adults. Neither is risk-free, and both require clinical oversight to use safely.